Changes to CLIA Waived Tests Effective July 1
The U.S. Food and Drug Administration (FDA) has announced new waived tests under the Clinical Laboratory Improvement Amendments (CLIA) of 1988. The tests become effect July 1 and will be implemented July 5.
The new tests include the following:
|82274QW/G0328QW||Jan. 1, 2011||Polymedco Poly Stat OC-light FOB Test|
|87804QW||Jan. 10, 2011||BTNX, Inc. Rapid Response Influenza A Test Cassette|
|87804QW||Jan. 10, 2011||BTNX, Inc. Rapid Response Influenza B|
The FDA informed the Centers for Medicare & Medicaid Services (CMS), which administers the CLIA regulations, that the Teco Diagnostics Uritek TC-101 Urine Analyzer was no longer categorized as a waived test under CLIA. It is now a moderate complexity test. CPT® code 81003QW Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrate, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, without microscopy has been removed from the CLIA Waived Test list. Report HCPCS Level II code G0433 Infectious agent antibody detection by enzyme-linked immunosorbent assay (ELISA) technique, HIV-1 and/or HIV-2, screening for the OraSure Technologies OraQuick ADVANCE® Rapid HIV-1/2 Antibody Test; and the code now assigned to the Clearview Complete HIV 1/2 test should be G0433QW in the Waived Test list, rather than 86703QW Antibody; HIV-1 and HIV-2, single assay.
Latest posts by admin aapc (see all)
- Message From Your Region 7 Representatives | October 2018 - October 24, 2018
- Message From Your Region 6 Representatives | October 2018 - October 24, 2018
- Message From Your Region 5 Representatives | October 2018 - October 24, 2018